A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism

Hormones (Athens). 2016 Oct;15(4):557-559. doi: 10.14310/horm.2002.1711.

Abstract

Objective: The coexistence of familial hypocalciuric hypercalcemia (FHH) and primary hyperparathyroidism (PHPT) is extremely rare. Genetic evidence has demonstrated a causal relationship between FHH and the presence of inactivating mutations in the calcium-sensing receptor gene.

Method: We herein report a 60-year-old German patient who was referred for hypercalcemia and increased PTH levels found incidentally during normal routine blood tests.

Results: The patient underwent surgical exploration and the diagnosis of PHPT was histologically confirmed. One week later, the follow-up blood tests revealed recurrent hypercalcemia, and the possibility of FHH was reconsidered. Genetic analysis was performed and revealed a novel heterozygous CaSR single missense mutation (Arg551Gly) within the extracellular CaSR domain.

Conclusion: We report a novel heterozygous missense inactivating mutation within the extracellular CaSR domain in a German subject with FHH and histologically proven PHPT.

Publication types

  • Case Reports

MeSH terms

  • Germany
  • Humans
  • Hypercalcemia / congenital*
  • Hypercalcemia / genetics
  • Hyperparathyroidism, Primary / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Receptors, Calcium-Sensing / genetics*

Substances

  • CASR protein, human
  • Receptors, Calcium-Sensing

Supplementary concepts

  • Hypocalciuric hypercalcemia, familial, type 1